...
首页> 外文期刊>RSC Advances >Alteration of glycosylation in serum proteins: a new potential indicator to distinguish non-diabetic renal diseases from diabetic nephropathy
【24h】

Alteration of glycosylation in serum proteins: a new potential indicator to distinguish non-diabetic renal diseases from diabetic nephropathy

机译:血清蛋白糖基化的改变:区分非糖尿病性肾脏疾病和糖尿病性肾病的新潜在指标

获取原文

摘要

Diabetic nephropathy (DN) and nondiabetic renal disease (NDRD) are two major categories of renal diseases in diabetes mellitus patients. The clinical differentiation among them is usually not so clear and effective. In this study, sera from DN and NDRD patients were collected, and glycan profiles of serum proteins from DN and NDRD patients were investigated and compared by using lectin microarray and lectin blot. Then, altered glycoproteins were enriched by lectin coupled magnetic particle conjugate and characterized by LC-MS/MS. We found significant change in glycan patterns between DN and NDRD patients. In particular, the relative abundance of the glycopattern of Galβ1-3GalNAc which was identified by BPL ( Bauhinia purpurea lectin) was significantly decreased in DN patients compared to four types of NDRD patients ( p < 0.05). Moreover, BPL blotting indicated that the proteins with a molecular weight of about 53 kDa exhibited low staining signal in DN compared to all NDRD groups, which was consistent with results of lectin microarrays. After enriching by BPL and identification by LC-MS/MS, a total of 235 and 258 proteins were characterized from NDRD and DN respectively. Among these, the relative abundance of 12 isolated serum proteins exhibited significantly alteration between DN and NDRD ( p < 0.05). Our findings indicated not only the relative abundance of Galβ1-3GalNAc on serum proteins but also certain glycoproteins modified with this glycopattern showed a difference between DN and NDRD patients. This suggested that the analysis of this alteration by using urine specimens may constitute an additional valuable diagnostic tool for differentiating DN and NDRD with a non-invasive method.
机译:糖尿病肾病(DN)和非糖尿病肾病(NDRD)是糖尿病患者的两大主要肾病类别。它们之间的临床区别通常不太清楚和有效。在这项研究中,收集了来自DN和NDRD患者的血清,并使用凝集素微阵列和凝集素印迹研究和比较了DN和NDRD患者的血清蛋白的聚糖谱。然后,通过凝集素偶联的磁性颗粒偶联物富集改变的糖蛋白,并通过LC-MS / MS表征。我们发现DN和NDRD患者之间的糖模式发生了显着变化。特别地,与四种类型的NDRD患者相比,DN患者中由BPL(紫荆花凝集素)鉴定的Galβ1-3GalNAc糖模式的相对丰度显着降低(p <0.05)。此外,BPL印迹表明,与所有NDRD组相比,分子量约为53 kDa的蛋白质在DN中表现出较低的染色信号,这与凝集素微阵列的结果一致。通过BPL富集并通过LC-MS / MS鉴定后,分别从NDRD和DN鉴定出总共235和258个蛋白质。其中,分离的12种血清蛋白的相对丰度表现出DN和NDRD之间的显着变化(p <0.05)。我们的发现不仅表明Galβ1-3GalNAc在血清蛋白上的相对丰度,而且用这种糖模式修饰的某些糖蛋白在DN和NDRD患者之间也显示出差异。这表明使用尿液标本对这种改变的分析可能构成了另一种有价值的诊断工具,可通过无创方法区分DN和NDRD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号